Clinical Trial

Fecal Microbiome Transplantation in Cirrhosis: Trial in Patients With Decompensated Cirrhosis

Study acronym: LiverGut
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This is a phase III, multicenter, double-blind, placebo-controlled, randomized clinical trial to evaluate the safety and efficacy of Fecal Microbiota Transplantation (FMT) from healthy subjects to patients with decompensated cirrhosis.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-07-30.
Status change: Not Yet Recruiting → Recruiting 2026-07-17
Trial Details
NCT Number NCT06533852
Lead Sponsor Consorcio Centro de Investigación Biomédica en Red (CIBER)
Conditions Decompensated Cirrhosis
Enrollment 190 participants
Start Date 2025-07-16
Primary Completion 2029-01 (estimated)
Study Completion 2029-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-20